Body Weight Changes: Clinical Trials

2,663 trials for Body Weight Changes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1685 completed, 314 unknown, 261 recruiting, 111 terminated. 1717 Not applicable, 227 Phase 2, 150 Phase 3, 121 Phase 4, 98 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable1717Completed 1145, Unknown 197, Recruiting 151, Active not recruiting 67, Not yet recruiting 58, Terminated 48, Withdrawn 42, Enrolling by invitation 7, Suspended 2
Phase 2227Completed 141, Recruiting 21, Terminated 20, Unknown 18, Not yet recruiting 12, Withdrawn 9, Active not recruiting 5, Enrolling by invitation 1
Phase 3150Completed 92, Recruiting 14, Unknown 14, Not yet recruiting 11, Terminated 11, Active not recruiting 4, Suspended 2, Withdrawn 2
Phase 4121Completed 63, Unknown 20, Recruiting 16, Not yet recruiting 7, Terminated 6, Active not recruiting 4, Withdrawn 4, Suspended 1
Phase 198Completed 70, Recruiting 9, Unknown 6, Not yet recruiting 4, Terminated 4, Active not recruiting 3, Enrolling by invitation 1, Withdrawn 1
Early Phase 111Completed 5, Recruiting 2, Unknown 2, Active not recruiting 1, Withdrawn 1

Follow Body Weight Changes: new trials by email Literature Review of Body Weight Changes trials Research Report on Body Weight Changes

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Learning Early Infant Feeding Cues
Learning Early Infant Feeding Cues - Responsive Feeding, Infants
Not applicableNot yet recruitingFlorida State University392027-07-012026-04-27
Simplifying Diet Tracking in a Digital Weight Loss Intervention
Simplified Dietary Self-Monitoring, Detailed Dietary Self-Monitoring, Core Behavioral Weight Loss Intervention - Overweight, Obesity
Not applicableNot yet recruitingStanford University3282027-05-012026-05-28
Optimization of Dietary Adherence in a Mobile Weight Loss Intervention
Core, Switch to Simplified Diet Monitoring, Goal Autonomy/Planning - Overweight and/or Obesity
Not applicableNot yet recruitingUNC Lineberger Comprehensive Cancer Center5802027-03-012026-05-15
Semaglutide for Weight Management During Hormone Therapy for Early Breast Cancer
Semaglutide (Wegovy®) - Breast Cancer (Early Breast Cancer), Obesity
Phase 2Not yet recruitingAarhus University Hospital322027-03-012026-11-02
Brain and Obesity Longitudinal Development: Neurobiological Mechanisms of Semaglutide Treatment of Adolescent Obesity
Semaglutide - Pediatric Obesity, Obesity
Not yet recruitingErin Mauney122027-03-012026-11-02
Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 Diabetes
Supervised exercise training, protein supplement, Standardized lifestyle counseling - Type 2 Diabetes (T2DM), Obesity & Overweight
Not applicableNot yet recruitingGerman Diabetes Center942027-02-012026-11-09
Addressing Food Access and Physical Activity to Improve Diabetes Prevention Outcomes Among Underserved African Americans
Culturally-tailored, enhanced adaption of Diabetes Prevention Program - Diabetes, Physical Activity
Not applicableNot yet recruitingUniversity of Missouri, Kansas City4082027-01-042026-06-09
Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer
Semaglutide (Wegovy) weekly injection, LNG-IUD (Progestin), Structured Weight Loss Program - Endometrial Atypical Hyperplasia, Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia
Phase 2Not yet recruitingThe Methodist Hospital Research Institute482027-01-012026-10-01
Study Evaluating the Metabolic Effects of pulsENDO Therapy in Adults With Type 2 Diabetes
pulsENDO Therapy - Diabetes Type 2, Diabetes
Not applicableNot yet recruitingEndogenex, Inc.3202027-01-012026-08-18
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
Endothelial cell collection - Obesity and Obesity-related Medical Conditions, Diabetes
RecruitingBettina Mittendorfer1002027-01-012026-05-07
Diabetes Prevention Through Genetics, Familial History and Behavior Change
LEGACY DPP, DPP - Prediabetes, Weight Loss
Phase 2 / Phase 3Not yet recruitingMorehouse School of Medicine4002027-01-012026-10-20
A Phase II Clinical Study Evaluating the Efficacy and Safety of SXRN Injection in Patients With Cancer Cachexia
SXRN Injection, Placebo - Cachexia-Anorexia Syndrome, Cachexia; Cancer
Phase 2Not yet recruitingJiangsu Guiqiong Pharmaceutical Co., Ltd.962026-12-012026-10-26
Weight Changes After Incretin-mimetics
discontinuation of weight loss medication - Obesity and Obesity-related Medical Conditions
Not applicableNot yet recruitingMedical College of Wisconsin522026-12-012026-02-24
Weight Loss Composition and Metabolic Adaptation During Hypocaloric Dieting
Hypocaloric Diet - Obesity
Not applicableNot yet recruitingTel Aviv University1502026-12-012026-10-08
Gut-Liver-Muscle Axis in Cancer Cachexia
Impact Advanced Recovery (Impact AR), Boost® High Protein + Beneprotein® - Head & Neck Cancer
Not applicableNot yet recruitingUniversity of Colorado, Denver202026-12-012026-11-05
Phase 1/2 Study of DS010 in Advanced Cancer Patients With Cachexia
DS010 injection - Cancer, Cachexia
Phase 1 / Phase 2RecruitingDartsbio Pharmaceuticals Ltd.582026-11-302026-11-06
Investigating the Effects of 24 Hour LEAP2 Infusion in Individuals With Overweight and Obesity
Liver-expressed antimicrobial peptide 2, Placebo - Obesity & Overweight
Phase 1 / Phase 2Not yet recruitingUniversity Hospital, Gentofte, Copenhagen182026-11-302026-10-27
Effect of Earmuffs on Physiological Stability, Sleep-Wake States, and Weight Gain in Preterm Neonates
Neonatal Earmuffs - Preterm Infants
Not applicableNot yet recruitingUniversity of Baghdad802026-11-202026-11-12
The Purpose of This Study is to Learn About the Safety and Effectiveness of Berobenatide in Women With Urine Leakage and With Obesity or Overweight
Berobenatide, Placebo - Urinary Incontinence, Stress, Overweight and/or Obesity
Phase 3Not yet recruitingPfizer9002026-11-172026-11-12
Building Opportunities for Nurturing Care to Enhance Child Development in Eastern and Southern Africa
Friendship Bench, Infant and Young Child Feeding (IYCF) Curriculum, Play-Based Curriculum - Neurodevelopment, Child Growth
Not applicableNot yet recruitingUniversity of Washington12602026-11-012026-03-03

Showing 20 of 2663. Sign in to see all of them.

Narrower conditions

Weight Loss (1806)  ·  Obesity (1296)  ·  Overweight (477)  ·  Cachexia (303)  ·  Weight Gain (303)  ·  Motor Activity (291)  ·  Gestational Weight Gain (134)  ·  Body Weight (111)  ·  Diabetes Mellitus, Type 2 (109)  ·  Neoplasms (103)  ·  Diabetes Mellitus (101)  ·  Metabolic Syndrome (100)  ·  Obesity, Morbid (92)  ·  Insulin Resistance (86)

Broader conditions

Pathological Conditions, Signs and Symptoms (2663)  ·  Signs and Symptoms (2658)  ·  Body Weight (2552)  ·  Nutritional and Metabolic Diseases (1713)  ·  Nutrition Disorders (1526)  ·  Overnutrition (1423)  ·  Overweight (953)  ·  Behavior (522)  ·  Metabolic Diseases (447)  ·  Glucose Metabolism Disorders (385)  ·  Endocrine System Diseases (322)  ·  Thinness (290)  ·  Weight Loss (277)  ·  Neoplasms by Site (192)

Interventions

Exercise (102)  ·  Diet (61)  ·  Caloric Restriction (49)  ·  semaglutide (30)  ·  Standard of Care (28)  ·  Nutrition Assessment (26)  ·  Diet Therapy (23)  ·  Gastric Bypass (23)  ·  Metformin (23)  ·  Control Groups (22)  ·  Bariatric Surgery (21)  ·  Behavior Therapy (20)  ·  Counseling (19)  ·  Liraglutide (18)  ·  Megestrol Acetate (18)

Sponsors

Wake Forest University Health Sciences (40)  ·  The Miriam Hospital (31)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (29)  ·  University of Alabama at Birmingham (27)  ·  University of Colorado, Denver (27)  ·  Pennington Biomedical Research Center (26)  ·  University of North Carolina, Chapel Hill (25)  ·  University of Pittsburgh (25)  ·  University of Pennsylvania (24)  ·  University of Kansas Medical Center (23)  ·  Duke University (22)  ·  University of California, San Diego (22)  ·  VA Office of Research and Development (22)  ·  Washington University School of Medicine (22)  ·  Stanford University (21)

Countries

United States (1312)  ·  Canada (106)  ·  China (89)  ·  United Kingdom (83)  ·  Germany (79)  ·  Spain (69)  ·  Denmark (67)  ·  Italy (57)  ·  France (53)  ·  Turkey (Türkiye) (51)  ·  Brazil (38)  ·  Norway (36)  ·  Sweden (36)  ·  Netherlands (34)  ·  Taiwan (34)

Top investigators

Samuel Klein, MD (9)  ·  David Crowley, MD (5)  ·  Holly Wyatt, MD (5)  ·  Jack A Yanovski, M.D. (5)  ·  James Hill, PhD (5)  ·  Jessica G LaRose, PhD (5)  ·  John M Jakicic, Ph.D. (5)  ·  Aminah Jatoi, MD (4)  ·  Cheryl L Rock, PhD, RD (4)  ·  David S Ludwig, MD, PhD (4)  ·  Deborah F. Tate, PhD (4)  ·  Hamid R Farshchi, MD, PhD (4)

Results publications

PMID 33512717, PMID 38375882, PMID 26708836, PMID 30230252, PMID 33238176, PMID 40839263, PMID 41029405, PMID 23661689, PMID 27206567, PMID 27659698, PMID 27888609, PMID 28472437, PMID 30651576, PMID 32002540, PMID 34544560, PMID 35538903, PMID 37652841, PMID 40705619, PMID 18753666, PMID 20145731, PMID 20222968, PMID 22085317, PMID 22127229, PMID 22513296, PMID 23229890, PMID 23364004, PMID 24081232, PMID 24500151, PMID 24670075, PMID 25475207, PMID 25972230, PMID 26395743, PMID 26641646, PMID 26906526, PMID 27116910, PMID 27676466, PMID 28494136, PMID 29777235, PMID 30475957, PMID 31004409, PMID 31012296, PMID 31155473, PMID 31409509, PMID 32118268, PMID 32651241, PMID 33240920, PMID 33344496, PMID 33677781, PMID 33789551, PMID 34611902

NIH funding

P50MD017338 (4), R01AG012161 (4), 2018 (3), 2023 (3), P20GM144269 (3), R01HL140574 (3), U10CA081920 (3), 2016 (2), 2017 (2), 8UL1GM118979-02 (2), K01HL141535 (2), K23AG051681 (2), K24DK065018 (2), P20NR011404 (2), P30CA043703 (2)